We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Varian Acquires MRI Magnet Manufacturer

By HospiMedica staff writers
Posted on 18 Oct 2004
Varian, Inc. More...
(Palo Alto, CA, USA) has agreed to acquire Magnex Scientific, Ltd. (Oxford, UK) for U.S.$32 million. Magnex designs and manufactures magnetic resonance imaging (MRI) magnets. It is also an international supplier of vertical high-resolution nuclear MR (NMR) magnets, superconductor magnets for Fourier transform mass spectroscopy (FTMS), and MR microscopy gradients.

In connection with the acquisition, Varian also plans to rationalize its field support administration in the United Kingdom, which is expected to result in charges to earnings totaling about $2.0 million. Magnex will be operated as a wholly owned subsidiary of Varian. Varian will continue its longtime partnership with Oxford Instruments Superconductivity, which supplies high-resolution magnets for the company's NMR spectrometer systems, and Magnex will continue to offer its complete range of MRI, NMR, and FTMS magnets to its existing customer base.

"The acquisition of Magnex is strategic to advancing Varian, Inc.'s drive into magnetic resonance imaging. Magnex's expertise in the design of MR imaging will help Varian, since magnet technology is core to both MR imaging and high-resolution NMR. Having this capability further supports Varian's efforts to expand the use of these information-rich detectors,” stated Garry W. Rogerson, president and CEO, Varian.

The acquisition follows a successful five-year relationship, during which Magnex has been manufacturing state-of-the-art MRI magnet systems for Varian. It also builds on Magnex's supply to Varian of the Actively Shielded 800 mHz magnet. "This acquisition affords Magnex the opportunity to accelerate the development of cutting-edge magnet technology to grow our position in MR imaging magnets as well as to improve customer care and after-sales support through Varian, Inc.'s global sales and support infrastructure. We look forward to this exciting new phase in the history of Magnex and its continuing development within the Varian, Inc.'s family,” remarked David Rayner, managing director and a founder of Magnex.


Related Links:
Varian, Inc.
Magnex Scientific

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infant Incubator
OKM 801
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.